Literature DB >> 20810763

Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.

Tomasz Jagielski1, Ewa Augustynowicz-Kopec, Thierry Zozio, Nalin Rastogi, Zofia Zwolska.   

Abstract

The spoligotyping-based population structure of multidrug-resistant (MDR) Mycobacterium tuberculosis strains isolated in Poland (n = 46), representing all culture-positive MDR tuberculosis (MDR-TB) cases, was compared to that of isoniazid (INH)-monoresistant strains (n = 71) isolated in 2004. The latter data set from a previous study (E. Augustynowicz-Kopeć, T. Jagielski, and Z. Zwolska, J. Clin. Microbiol. 2008, 46:4041-4044) represented 87% of all INH-monoresistant strains. The clustering rates and genotypic-diversity indexes for the 2 subpopulations were not significantly different (P = 0.05). The results were entered in the SITVIT2 database to assign specific shared type designations, corresponding genotypic lineages, and geographical distributions and compared to available data from neighboring countries (Germany, n = 704; Czech Republic, n = 530; Sweden, n = 379; Kaliningrad, Russia, n = 90) and strains from previous studies in Poland (n = 317). MDR strains resulted in 27 patterns (20 unique strains within the study and 7 clusters containing 2 to 6 isolates per cluster with a clustering rate of 56.5%) and belonged to the following genotypic lineages: ill-defined T family (28.3%), Haarlem (17.4%), Latin American and Mediterranean (LAM) (13%), Beijing (8.7%), S family (4.35%), and the X clade (2.17%). Comparison of the genetic structure of the MDR strains with that of INH-monoresistant strains showed that a total of 9 patterns were shared by both groups; these represented 1/3 of the MDR strains and 2/3 of the INH-monoresistant strains. Interestingly, 76.1% of the MDR isolates and 71.8% of the INH-resistant isolates yielded spoligotypes that were previously reported from Poland. The observation that nearly half of the spoligotypes identified among both MDR (48.1%) and INH-monoresistant (43.3%) M. tuberculosis isolates were present in Poland's neighboring countries suggested that a significant proportion of MDR and INH-resistant TB cases in Poland were caused by strains actively circulating in Poland or its neighbors. Our results corroborate the leading role of the T and Haarlem genotypes in the epidemiology of drug-resistant TB in Poland. Nevertheless, the LAM and Beijing family strains that infected, correspondingly, 13% and 9% of patients with MDR-TB were absent among the strains from patients with INH-monoresistant TB, suggesting that a proportion of MDR-TB cases in Poland are due to ongoing transmission of MDR clones exhibiting specific genotypes. Study of the population genetic relationships between MDR and INH-monoresistant strains by drawing minimum spanning trees showed that ill-defined T1 sublineage strains (1/3 of all INH-monoresistant strains), represented by its prototype, SIT53, constituted the central node of the tree, followed by strains belonging to the well-defined H3, H1, and S subgroups. However, the MDR group, in addition, contained LAM (n = 6) and Beijing (n = 4) lineage isolates. With the exception of the 4 Beijing lineage strains in the latter group and a single orphan isolate in the INH-monoresistant group, none of the remaining 112/117 isolates belonged to principal genetic group 1 (PGG1) in our study. Given the high rate of clustering and the near absence of immigrants in the study, the persistence of MDR-TB in Poland seems to result from active transmission of MDR strains within the autochthonous population, the bulk of it caused by evolutionarily recent tubercle bacilli.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810763      PMCID: PMC3020827          DOI: 10.1128/JCM.00572-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  47 in total

1.  Molecular epidemiology of drug-resistant tuberculosis in Hungary.

Authors:  Csaba Ködmön; Stefan Niemann; Judit Lukács; Eva Sör; Sándor Dávid; Akos Somoskövi
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

2.  Molecular epidemiology of drug-resistant tuberculosis in Sweden.

Authors:  Solomon Ghebremichael; Ramona Petersson; Tuija Koivula; Alexandra Pennhag; Victoria Romanus; Ingela Berggren; Björn Petrini; Sven Hoffner; Gunilla Källenius
Journal:  Microbes Infect       Date:  2008-03-29       Impact factor: 2.700

3.  Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia.

Authors:  M Y Lipin; V N Stepanshina; I G Shemyakin; T M Shinnick
Journal:  Clin Microbiol Infect       Date:  2007-04-02       Impact factor: 8.067

4.  [Incidence of tuberculosis in Poland 2004 and its trends].

Authors:  Ireneusz Szczuka
Journal:  Pneumonol Alergol Pol       Date:  2005

5.  Use of spoligotype analysis to detect laboratory cross-contamination.

Authors:  B Nivin; J Driscoll; T Glaser; P Bifani; S Munsiff
Journal:  Infect Control Hosp Epidemiol       Date:  2000-08       Impact factor: 3.254

6.  Three-year longitudinal study of genotypes of Mycobacterium tuberculosis isolates in Tuscany, Italy.

Authors:  Nicoletta Lari; Laura Rindi; Daniela Bonanni; Nalin Rastogi; Christophe Sola; Enrico Tortoli; Carlo Garzelli
Journal:  J Clin Microbiol       Date:  2007-04-25       Impact factor: 5.948

7.  Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients.

Authors:  Parissa Farnia; Mohamad Reza Masjedi; Mehdi Mirsaeidi; Foroozan Mohammadi; Veronique Vincent; Moslem Bahadori; Ali Akbar Velayati
Journal:  J Infect       Date:  2006-02-14       Impact factor: 6.072

8.  Contribution of spoligotyping to the characterization of the population structure of Mycobacterium tuberculosis isolates in Portugal.

Authors:  Suzana David; Diana Raposo Ribeiro; Abílio Antunes; Clara Portugal; Luísa Sancho; José Germano de Sousa
Journal:  Infect Genet Evol       Date:  2007-05-21       Impact factor: 3.342

9.  Molecular analysis of drug-resistant Mycobacterium tuberculosis isolates collected in central Poland.

Authors:  E Augustynowicz-Kopeć; T Jagielski; M Kozińska; A Zabost; M Klatt; Z Zwolska
Journal:  Clin Microbiol Infect       Date:  2008-04-05       Impact factor: 8.067

10.  [Molecular strain typing contribution to epidemiology of tuberculosis in Limousin (1998 to 2006)].

Authors:  H Bezanahary; M-C Baclet; C Sola; V Gazaille; P Turlure; P Weinbreck; F Denis; C Martin
Journal:  Med Mal Infect       Date:  2008-04-18       Impact factor: 2.152

View more
  17 in total

1.  Inadequacies of minimum spanning trees in molecular epidemiology.

Authors:  Stephen J Salipante; Barry G Hall
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

Review 2.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

3.  Molecular assessment, drug-resistant profile, and spacer oligonucleotide typing (spoligotyping) of Mycobacterium tuberculosis strains from Tamaulipas, México.

Authors:  Virgilio Bocanegra-García; Elvira Garza-González; Wendy Lizeth Cruz-Pulido; Yahaira Lizeth Guevara-Molina; Rubén Cantú-Ramírez; Gloria M González; Gildardo Rivera; José P Palma-Nicolas
Journal:  J Clin Lab Anal       Date:  2014-01-06       Impact factor: 2.352

4.  Mycobacterium tuberculosis Latin American-Mediterranean family and its sublineages in the light of robust evolutionary markers.

Authors:  Igor Mokrousov; Anna Vyazovaya; Olga Narvskaya
Journal:  J Bacteriol       Date:  2014-02-28       Impact factor: 3.490

5.  Mycobacterium tuberculosis of the RDRio genotype is the predominant cause of tuberculosis and associated with multidrug resistance in Porto Alegre City, South Brazil.

Authors:  Elis Regina Dalla Costa; Luiz Claudio Oliveira Lazzarini; Paulo Fernado Perizzolo; Chyntia Acosta Díaz; Fernanda S Spies; Lucas Laux Costa; Andrezza W Ribeiro; Caroline Barroco; Sandra Jungblut Schuh; Marcia Aparecida da Silva Pereira; Claudia F Dias; Harrison M Gomes; Gisela Unis; Arnaldo Zaha; Pedro E Almeida da Silva; Philip N Suffys; Maria L R Rossetti
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948

6.  A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.

Authors:  T Jagielski; A Brzostek; A van Belkum; J Dziadek; E Augustynowicz-Kopeć; Z Zwolska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-20       Impact factor: 3.267

7.  A first insight on the population structure of Mycobacterium tuberculosis complex as studied by spoligotyping and MIRU-VNTRs in Santiago, Chile.

Authors:  María Elvira Balcells; Patricia García; Paulina Meza; Carlos Peña; Marcela Cifuentes; David Couvin; Nalin Rastogi
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

8.  Using genomics data to reconstruct transmission trees during disease outbreaks.

Authors:  M D Hall; M E J Woolhouse; A Rambaut
Journal:  Rev Sci Tech       Date:  2016-04       Impact factor: 1.181

Review 9.  Prevalence and occurrence rate of Mycobacterium tuberculosis Haarlem family multi-drug resistant in the worldwide population: A systematic review and meta-analysis.

Authors:  Rashid Ramazanzadeh; Daem Roshani; Pegah Shakib; Samaneh Rouhi
Journal:  J Res Med Sci       Date:  2015-01       Impact factor: 1.852

10.  Genetic variability of Mycobacterium tuberculosis complex in patients with no known risk factors for MDR-TB in the North-Eastern part of Lima, Peru.

Authors:  Francesca Barletta; Larissa Otero; Jimena Collantes; Belisa Asto; Bouke C de Jong; Carlos Seas; Leen Rigouts
Journal:  BMC Infect Dis       Date:  2013-08-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.